Found: 38
Select item for more details and to access through your institution.
A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Complex Factors and Challenges that Affect the Pharmacology, Safety and Efficacy of Nanocarrier Drug Delivery Systems.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 1, p. 114, doi. 10.3390/pharmaceutics13010114
- By:
- Publication type:
- Article
It takes a village to raise awareness of and to address surface contamination of hazardous drugs.
- Published in:
- Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 7, p. 558, doi. 10.1177/1078155217724650
- By:
- Publication type:
- Article
Development and evaluation of a novel product to remove surface contamination of hazardous drugs.
- Published in:
- Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 2, p. 103, doi. 10.1177/1078155215621151
- By:
- Publication type:
- Article
First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1047, doi. 10.1007/s10637-021-01081-x
- By:
- Publication type:
- Article
Nonaqueous Gel for the Transdermal Delivery of a DTPA Penta-ethyl Ester Prodrug.
- Published in:
- AAPS Journal, 2013, v. 15, n. 2, p. 523, doi. 10.1208/s12248-013-9459-5
- By:
- Publication type:
- Article
Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse model.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211053700
- By:
- Publication type:
- Article
Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse model.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211053700
- By:
- Publication type:
- Article
Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0061359
- By:
- Publication type:
- Article
Patterns and characteristics associated with surface contamination of hazardous drugs in hospital pharmacies.
- Published in:
- American Journal of Health-System Pharmacy, 2019, v. 76, n. 9, p. 591, doi. 10.1093/ajhp/zxz033
- By:
- Publication type:
- Article
Schedule-dependent Efficacy of Camptothecins in Models of Human Cancer<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 188, doi. 10.1111/j.1749-6632.1996.tb26388.x
- By:
- Publication type:
- Article
Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors [Corrigendum].
- Published in:
- International Journal of Nanomedicine, 2019, v. 14, p. 5751, doi. 10.2147/IJN.S207276
- By:
- Publication type:
- Article
Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors.
- Published in:
- International Journal of Nanomedicine, 2015, v. 10, p. 1201, doi. 10.2147/IJN.S62911
- By:
- Publication type:
- Article
2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model.
- Published in:
- International Journal of Nanomedicine, 2014, v. 9, p. 3601, doi. 10.2147/IJN.S66040
- By:
- Publication type:
- Article
Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients.
- Published in:
- International Journal of Nanomedicine, 2012, v. 7, p. 5555, doi. 10.2147/IJN.S35751
- By:
- Publication type:
- Article
MerTK as a therapeutic target in glioblastomaas a therapeutic target in glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 92, doi. 10.1093/neuonc/nox111
- By:
- Publication type:
- Article
Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 12, p. 2073, doi. 10.1007/s00228-013-1580-y
- By:
- Publication type:
- Article
Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of formulation on the iontophoretic delivery of the FOLFIRINOX regimen for the treatment of pancreatic cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 3, p. 417, doi. 10.1007/s00280-007-0620-7
- By:
- Publication type:
- Article
Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 5, p. 631, doi. 10.1007/s00280-005-0084-6
- By:
- Publication type:
- Article
Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 2, p. 182, doi. 10.1007/s00280-004-0925-8
- By:
- Publication type:
- Article
Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 6, p. 487, doi. 10.1007/s00280-004-0835-9
- By:
- Publication type:
- Article
Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 329, doi. 10.1007/s00280-003-0719-4
- By:
- Publication type:
- Article
Phase I study of docetaxel and topotecan in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 6, p. 442, doi. 10.1007/s002800000180
- By:
- Publication type:
- Article
Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist's Perspective.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 3, p. 30, doi. 10.3390/antib10030030
- By:
- Publication type:
- Article
Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients.
- Published in:
- Antibodies (2073-4468), 2019, v. 8, n. 1, p. 3, doi. 10.3390/antib8010003
- By:
- Publication type:
- Article
Factors Affecting the Pharmacology of Antibody-Drug Conjugates.
- Published in:
- Antibodies (2073-4468), 2018, v. 7, n. 1, p. 10, doi. 10.3390/antib7010010
- By:
- Publication type:
- Article
Population Pharmacokinetics of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 2, p. 180, doi. 10.1177/0091270010394851
- By:
- Publication type:
- Article
Challenges in preclinical to clinical translation for anticancer carrier-mediated agents.
- Published in:
- WIREs: Nanomedicine & Nanobiotechnology, 2016, v. 8, n. 5, p. 642, doi. 10.1002/wnan.1394
- By:
- Publication type:
- Article
Effect of Obesity on the Pharmacokinetics and Pharmacodynamics of Anticancer Agents.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, p. S85, doi. 10.1002/jcph.2326
- By:
- Publication type:
- Article
Genetically Engineered Cancer Models, But Not Xenografts, Faithfully Predict Anticancer Drug Exposure in Melanoma Tumors.
- Published in:
- Oncologist, 2012, v. 17, n. 10, p. 1303, doi. 10.1634/theoncologist.2012-0274
- By:
- Publication type:
- Article
Concept and Clinical Evaluation of Carrier-Mediated Anticancer Agents.
- Published in:
- Oncologist, 2008, v. 13, n. 3, p. 248, doi. 10.1634/theoncologist.2007-0180
- By:
- Publication type:
- Article
From Immunotoxicity to Nanotherapy: The Effects of Nanomaterials on the Immune System.
- Published in:
- Toxicological Sciences, 2014, v. 138, n. 2, p. 249, doi. 10.1093/toxsci/kfu005
- By:
- Publication type:
- Article
Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 6, p. 476, doi. 10.1093/jnci/djs002
- By:
- Publication type:
- Article
Pharmacokinetics and toxicity of subcutaneous administration of carboplatin in poloxamer 407 in a rodent model pilot study.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0186018
- By:
- Publication type:
- Article